Cision PR Newswire

Zai Lab Announces First-Time Inclusion of KarXT and VYVGART Hytrulo® in China’s 2026 National Reimbursement Drug List, Expanding Access to Key Growth Products

SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...

Innovative Immunology Biotech Windward Bio Lists on Nasdaq

SHANGHAI, Nov. 14, 2026 /PRNewswire/ -- Windward Bio, a portfolio company of Qiming Venture...

WeFetch AI Corp. Is the New Name of GreenCore Solutions Corp.

gtinfetch.ai, WeFetch.ai's lead product, removes the guess from artificial intelligence (AI) shopping: the right...

Hesai Signs New $40 Million Lidar Contract with Leading U.S. Robotaxi Company

PALO ALTO, Calif., Sept. 15, 2025 /PRNewswire/ -- Hesai Technology (Nasdaq: HSAI), the global leader in lidar solutions for autonomous mobility, today announced the...

UWANT Launches Self-Emptying Vacuum Cleaner V500 in Japan, Poised to Disrupt the Market at the ¥20,000 Price Point

TOKYO, Sept. 15, 2025 /PRNewswire/ -- UWANT, an innovator in home cleaning technology, proudly announces the launch of the UWANT V500 Self-Emptying Vacuum Cleaner...

Thunes Expands Real-Time Cross-Border Payments to Saudi Arabia

LONDON and RIYADH, Saudi Arabia, Sept. 15, 2025 /PRNewswire/ -- Thunes, the Smart Superhighway to move money around the world, has announced the rollout...

EEF’s Sichuan Panda Conservation and Smart Meteorology Study Tour Post-Event, Sharing Session Inspires Youth on ESG, Conservation, and Cross-Border Collaboration

Sponsored by The Hong Kong Jockey Club, Jointly Organized by Earth Environmental Foundation and Chengdu University of Information Technology HONG KONG, Sept. 15,...

Akeso Announces First Patient Dose in Global Registrational Trial of Cadonilimab (PD-1/CTLA-4) for PD-1 Treatment-Resistant Hepatocellular Carcinoma

HONG KONG, Sept. 15, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in its...